Heart Failure NYHA Class II: Clinical Trials

1 trial for Heart Failure NYHA Class II, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Heart Failure NYHA Class II: new trials by email Literature Review of Heart Failure NYHA Class II trials Research Report on Heart Failure NYHA Class II

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biomarker Study: Heart Failure Patients at Risk
Angiotensin 1-7, Saline solution - Heart Failure NYHA Class II, Heart Failure NYHA Class III
Phase 1 / Phase 2UnknownUniversity of Arizona402022-04-012022-04-20

Narrower conditions

Heart Failure (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)

Interventions

Saline Solution (1)  ·  angiotensin I (1-7) (1)

Sponsors

University of Arizona (1)

Countries

United States (1)

Top investigators

Lee Ryan, Ph.D. (1)